Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM


Premature cardiovascular disease is common in insulin-dependent diabetic (IDDM) patients who develop diabetic nephropathy. Genetic polymorphism within the renin-angiotensin system has been implicated in the aetiology of a number of cardiovascular disorders; these loci are therefore candidate genes for susceptibility to diabetic renal disease. We have examined the angiotensin converting enzyme insertion/deletion polymorphism and angiotensinogen methionine 235 threonine polymorphism in a large cohort of Caucasian patients with IDDM and diabetic nephropathy. Patients were classified as having nephropathy by the presence of persistent dipstick positive proteinuria (in the absence of other causes), retinopathy and hypertension (n=242). Three groups were examined for comparison: ethnically matched non-diabetic subjects (n=187); a geographically defined cohort of newly diagnosed diabetic patients (n=341); and IDDM patients with long duration of disease (>15 years) and no evidence of overt nephropathy (n=166). No significant difference was seen in distribution of angiotensin converting enzyme or angiotensinogen genotypes between IDDM patients with nephropathy and recently diagnosed diabetic subjects (p=0.282 and 0.584, respectively), nor the long-duration non-nephropathy diabetic subjects (p=0.701 and 0.190, respectively). We conclude that these genetic loci are unlikely to influence susceptibility to diabetic nephropathy in IDDM in the United Kingdom.

This is a preview of subscription content, log in to check access.



Insulin-dependent diabetes mellitus


angiotensin converting enzyme


polymerase chain reaction


long duration-non-nephropathy group




renin-angiotension system


  1. 1.

    Borch-Johnsen K, Andersen JK, Deckert T (1985) The effect of proteinuria on relative mortality in type 1 diabetes. Am J Med 78: 785–794

  2. 2.

    Andersen AR, Christiansen JS, Andersen JK, Kreiner JK, Deckert T (1983) Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496–501

  3. 3.

    Seaquist ER, Goetz FC, Rich S, Barbosa J (1989) Familial clustering of diabetic kidney disease. Evidence of genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161–1165

  4. 4.

    Borch-Johnsen K, Norgaard K, Hommel E et al. (1992) Is diabetic nephropathy an inherited complication? Kidney Int 41: 719–722

  5. 5.

    Rigat B, Hubert C, Corvol P, Soubrier F (1992) PCR detection of the insertion/deletion polymorphism of the human angiotensin converting gene (DCP)(dipeptidyl carboxypeptidase 1). Nuc Acid Res 20: 1433

  6. 6.

    Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion deletion polymorphism in the angiotensin 1 converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343–1346

  7. 7.

    Cambien F, Poirier O, Lecerf L et al. (1992) Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature 359: 641–644

  8. 8.

    Raynolds MV, Bristow MR, Bush EW et al. (1993) Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 342: 1073–1075

  9. 9.

    Schunkert H, Hense HW, Holmer SR et al. (1994) Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 330: 1634–1638

  10. 10.

    Marian AJ, Yu QT, Workman R, Greve G, Roberts R (1993) Angiotensin converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 342: 1085–1086

  11. 11.

    Ruiz J, Blanche H, Cohen N (1994) Insertion/deletion polymorphism of the angiotensin converting enzyme gene is strongly associated with coronary heart disease in non-insulin dependent diabetes mellitus. Proc Natl Acad Sci 91: 3662–3665

  12. 12.

    Hallab M, Bled F, Ebran JM et al. (1992) Elevated serum angiotensin converting enzyme activity in type 1, insulin dependent diabetic subjects with persistent microalbuminuria. Acta Diabetol 29: 82–85

  13. 13.

    Bjork S, Mulec H, Johnsen SA, Norden G, Aurell M (1992) Renal protective effect of enalapril in diabetic nephropathy. BMJ 304: 339–343

  14. 14.

    Hilbert P, Lindpainter K, Lincoln SE et al. (1991) Chromosomal mapping of two genetic loci associated with blood pressure in hereditary hypertensive rats. Nature 353: 521–529

  15. 15.

    Doria A, Warram JH, Krolewski AS (1994) Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin 1 converting enzyme gene. Diabetes 43: 690–695

  16. 16.

    Marre M, Bernadet P, Gallois Y et. al. (1994) Relationships between angiotensin 1 converting enzyme gene polymorphism, plasma levels and diabetic retinal and renal complications. Diabetes 43: 384–388

  17. 17.

    Schmidt S, Schone N, Ritz E (1995) Association of ACE gene polymorphism and diabetic nephropathy? Kid Int 47: 1176–1181

  18. 18.

    Tarnow L, Cambien F, Rossing P et al. (1995) Lack of relationship between an insertion/deletion polymorphism in the angiotensin I converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44: 489–494

  19. 19.

    Rabensteiner D, Mayer G, Abrahamian H et al. (1995) Relationship between angiotensin-1-converting enzyme polymorphism and microangiopathy in IDDM subjects. Diabetologia 38 [Suppl] 1: A227 (Abstract)

  20. 20.

    Hibberd ML, Millward BA, Demaine AG (1995) Angiotensin converting enzyme genotypes and complications in type 1 diabetes. Diabetologia 38 [Suppl] 1: A227 (Abstract)

  21. 21.

    Chaturverdi N, Talmud P, Fuller JH (1995) Angiotensin converting enzyme (ACE) gene polymorphisms and complications in insulin dependent diabetes mellitus (IDDM). Diabetologia 38 [Suppl] 1: A227 (Abstract)

  22. 22.

    Jeunemaitre X, Soubrier F, Kotelevtsev YV et al. (1992) Molecular basis of human hypertension: role of angiotensinogen. Cell 71: 169–180

  23. 23.

    Walker WG, Whelton PK, Saito H, Russell RP, Hermann J (1979) Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1: 287–291

  24. 24.

    Viberti GC, Keen H, Wiseman MJ (1985) Raised arterial pressure in parents of proteinuric insulin dependent diabetics. BMJ 295: 515–517

  25. 25.

    Forsblom CM, Groop PH, Ekstrand A, Groop LC (1992) Predictive value of microalbuminuria in patients with insulin dependent diabetes of long duration. BMJ 305: 1051–1053

  26. 26.

    Shanmugam V, Sell KW, Saha BK (1993) Mistyping ACE heterozygotes. PCR Methods and Applications 3: 120–121

  27. 27.

    Russ AP, Maerz W, Ruzicka V, Stein U, Gross W (1993) Rapid detection of the hypertension associated Met 235-Thr allele of the human angiotensinogen gene. Hum Mol Gen 2: 609–610

  28. 28.

    Satsangi J, Jewell DP, Welsh K, Bunce M, Bell JI (1994) Effect of heparin on polymerase chain reaction. Lancet 343: 1509–1510(letter)

  29. 29.

    Katsuya T, Koike G, Yee TW et al. (1995) Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 345: 1600–1603

  30. 30.

    Richards NT, Greaves I, Lee SJ, Howie AJ, Adu D, Michael J (1992) Increased prevalence of renal biopsy findings other than diabetic glomerulopathy in type 2 diabetes mellitus. Nephrol Dial Trans 7: 397–399

  31. 31.

    Cox NJ, Bell GI (1989) Disease associations. Chance, artifact or susceptibility genes? Diabetes 38: 947–950

  32. 32.

    Tarnow L, Cambien F, Rossing P et al. (1995) Insertion/deletion polymorphism in the angiotensin 1 converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 38: 798–803

  33. 33.

    Harden PN, Geddes C, Rowe PA et al. (1995) Polymorphisms in angiotensin converting enzyme gene and progression of IgA nephropathy. Lancet 345: 1540–1542

  34. 34.

    Khan I, MacCleod AM (1995) ACE genotype and progression of IgA nephropathy. Lancet 345: 570

  35. 35.

    Van Essen G, Rensma PL, de Zeeuw D, Sluiter H, Apperloo A, de Jong PE (1996) Association between angiotensin coverting enzyme gene polymorphism and failure of renoprotective therapy. Lancet 347: 94–95

  36. 36.

    Walker JD, Tariq T, Viberti GC (1990) Sodium lithium countertransport activity in red cells of patients with insulin dependent diabetes and nephropathy and their parents. BMJ 301: 635–638

Download references

Author information

Correspondence to Dr. T. A. Chowdhury.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chowdhury, T.A., Dronsfield, M.J., Kumar, S. et al. Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM. Diabetologia 39, 1108–1114 (1996).

Download citation


  • Insulin-dependent diabetes mellitus
  • polymerase chain reaction
  • diabetic nephropathy
  • angiotensinogen
  • angiotensin converting enzyme
  • gene polymorphism